Characterization of the vasorelaxation to methanandamide in rat gastric arteries

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 11, 2006, Pages 1121-1132

  Breyne, Joke ^a   Van De Voorde, Johan ^a   Vanheel, Bert ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Cannabinoid receptors; Endothelial factors; Vanilloid receptors; Vasoactive agents; Vasorelaxation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CAPSAICIN; CAPSAZEPINE; METHANANDAMIDE; NIFEDIPINE; NORADRENALIN; POTASSIUM CHANNEL; POTASSIUM ION; TETRYLAMMONIUM CHLORIDE; VANILLOID RECEPTOR; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM DEPLETION; CALCIUM TRANSPORT; CHANNEL GATING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; EXTRACELLULAR CALCIUM; FEMALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; VASODILATATION;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; ARACHIDONIC ACIDS; ARTERIES; CALCITONIN GENE-RELATED PEPTIDE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHLORIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; POTASSIUM; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; STOMACH; TRPV CATION CHANNELS; VASODILATION; VASODILATOR AGENTS;

EID: 33947523954     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-058     Document Type: Article

References (66)

1. Abadji, V., Lin, S., Taha, G., Griffin, G., Stevenson, L.A., Pertwee, R.G., and Makriyannis, A. 1994. (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J. Med. Chem. 37: 1889-1893. doi:10.1021/jm00038a020.
2. Ahluwalia, J., Urban, L., Bevan, S., and Nagy, I. 2003. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci. 17: 2611-2618. doi:10.1046/j.1460-9568.2003. 02703.x.
3. 1 receptor protein. J. Cardiovasc. Pharmacol. 44: 517-519.
4. Brain, S.D., and Grant, A.D. 2004. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev. 84: 903-934. doi: 10.1152/physrev.00037.2003.
5. 1 receptors on perivascular CGRP containing nerves. J. Cardiovasc. Pharmacol. 47: 303-309. doi:10.1097/01.fjc.0000205053.53946.10.
6. Chaytor, A.T., Martin, P.E., Evans, W.H., Randall, M.D., and Griffith, T.M. 1999. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J. Physiol. 520: 539-550. doi:10.1111/j.1469-7793.1999.00539.x.
7. Chemin, J., Monteil, A., Perez-Reyes, E., Nargeot, J., and Lory, P. 2001. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J. 20: 7033-7040. doi:10.1093/emboj/20.24.7033.
8. Childers, S.R., Fleming, L., Konkoy, C., Marckel, D., Pacheco, M., Sexton, T., and Ward, S. 1992. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain. Ann. N. Y. Acad. Sci. 654: 33-51.
9. Deutsch, D.G., Goligorsky, M.S., Schmid, P.C., Krebsbach, R.J., Schmid, H.H.O., Das, S.K., et al. 1997. Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. 100: 1538-1546.
10. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., et al. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Washington, D.C.), 258: 1946-1949.
11. Ca channels. Circ. Res. 97: 1270-1279. doi:10.1161/01.RES. 0000194321.60300.d6.
12. Ellis, E.F., Moore, S.F., and Willoughby, K.A. 1995. Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am. J. Physiol. 269: H1859-H1864.
13. Ford, W.R., Honan, S.A., White, R., and Hiley, C.R. 2002. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br. J. Pharmacol. 135: 1191-1198. doi:10.1038/sj.bjp.0704565.
14. 1 receptors. Eur. J. Pharmacol. 307: 331-338. doi:10.1016/0014-2999(96)00279-8.
15. 2+ channel current. Am. J. Physiol. 276: H2085-H2093.
16. 1-mediated inhibition of stress-induced gastric ulcers in rats. Naunyn Schmiedebergs Arch. Pharmacol. 363: 241-244.
17. 2 cannabinoid receptors and their metabolic stability. Bioorg. Med. Chem. 9: 1673-1684. doi:10.1016/S0968-0896(01) 00088-8.
18. Gray, D.W., and Marshall, I. 1992. Human alpha calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br. J. Pharmacol. 107: 691-696.
19. Henry, D.J., and Chavkin, C. 1995. Activation of inwardly rectifying potassium channels (Girk1) by coexpressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett. 186: 91-94. doi:10.1016/0304-3940(95) 11289-9.
20. Hillard, C.J. 2000. Endocannabinoids and vascular function. J. Pharmacol. Exp. Ther. 294: 27-32.
21. 2+ influx. Br. J. Pharmacol. 139: 585-597. doi:10.1038/sj.bjp.0705280.
22. Holzer, P. 1998. Neural emergency system in the stomach. Gastroenterology, 114: 823-839. doi:10.1016/S0016-5085(98)70597-9.
23. Holzer, P., and Lippe, I.T. 1988. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa. Neuroscience, 27: 981-987. doi:10.1016/0306-4522(88)90201-1.
24. Holzer, P., and Pabst, M.A. 1999. Visceral afferent neurons: role in gastric mucosal protection. News Physiol. Sci. 14: 201-206.
25. Hosohata, Y., Quock, R.M., Hosohata, K., Makriyannis, A., Consroe, P., Roeske, W.R., and Yamamura, H.I. 1997. AM630 antagonism of cannabinoid- stimulated [35S]GTP gamma S binding in the mouse brain. Eur. J. Pharmacol. 321: R1-R3. doi:10.1016/S0014-2999(97)00047-2.
26. Howlett, A.C. 1995. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35: 607-634. doi:10.1146/annurev.pa.35.040195.003135.
27. Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., et al. 2002. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54: 161-202. doi:10.1124/pr.54.2.161.
28. 2 receptors. Proc. Natl. Acad. Sci. U.S.A. 96: 14136-14141. doi:10.1073/pnas.96.24.14136.
29. Johnson, D.E., Heald, S.L., Dally, R.D., and Janis, R.A. 1993. Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding. Prostaglandins Leukot. Essent. Fatty Acids, 48: 429-437. doi:10.1016/0952-3278(93)90048-2.
30. Karaki, H., Ozaki, H., Hori, M., MitsuiSaito, M., Amano, K.I., Harada, K.I., et al . 1997. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49: 157-230.
31. Kinoshita, Y., Inui, T., and Chiba, T. 1993. Calcitonin gene-related peptide: a neurotransmitter involved in capsaicin-sensitive afferent nerve-mediated gastric mucosal protection. J. Clin. Gastroen-terol. 17: S27-S32.
32. Lang, W., Qin, C., Lin, S., Khanolkar, A.D., Goutopoulos, A., Fan, P., et al. 1999. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. J. Med. Chem. 42: 896-902. doi:10.1021/jm980461j.
33. Langton, P.D., Nelson, M.T., Huang, Y., and Standen, N.B. 1991. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am. J. Physiol. 260: H927-H934.
34. Li, Y.J., and Duckies, S.P. 1992. Effect of endothelium on the actions of sympathetic and sensory nerves in the perfused rat mesentery. Eur. J. Pharmacol. 210: 23-30. doi:10.1016/0014-2999(92)90647-M.
35. Mackie, K., and Hille, B. 1992. Cannabinoids inhibit N-type calcium channels in neuroblastoma glioma cells. Proc. Natl. Acad. Sci. U.S.A. 89: 3825-3829. doi:10.1073/pnas.89.9.3825.
36. Mackie, K., Lai, Y., Westenbroek, R., and Mitchell, R. 1995. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in Att20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15: 6552-6561.
37. Maggi, C.A., Giuliani, S., and Zagorodnyuk, V. 1996. Calcitonin gene-related peptide (CGRP) in the circular muscle of guinea-pig colon: role as inhibitory transmitter and mechanisms of relaxation. Regul. Pept. 61: 27-36. doi:10.1016/0167-0115(95) 00133-6.
38. + channel TASK-1. EMBO J. 20: 47-54. doi:10.1093/emboj/20.1. 47.
39. + channels of vascular smooth muscle cells via adenylate cyclase. Basic Res. Cardiol. 90: 332-336. doi:10.1007/ BF00797911.
40. Mizuguchi, S., Ohno, T., Hattori, Y., Kamata, K., Arai, K., Saeki, T., et al. 2005. Calcitonin gene-related peptide released by capsaicin suppresses myoelectrical activity of gastric smooth muscle. J. Gastroenterol. Hepatol. 20: 611-618. doi:10.1111/j.1440-1746.2004.03764.x.
41. Mukhopadhyay, S., Chapnick, B.M., and Howlett, A.C. 2002. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am. J. Physiol. Heart Circ. Physiol. 282: H2046-H2054.
42. Mulvany, M.J., and Halpern, W. 1976. Mechanical properties of vascular smooth muscle cells in situ. Nature (London), 260: 617-619. doi:10.1038/260617a0.
43. Nicholson, R.A., Liao, C., Zheng, J., David, L.S., Coyne, L., Errington, A.C., Singh, G., and Lees, G. 2003. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res. 978: 194-204. doi:10.1016/S0006-8993(03)02808-7.
44. O'Sullivan, S.E., Kendall, D.A., and Randall, M.D. 2004. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. Br. J. Pharmacol. 142: 435-442. doi:10.1038/sj.bjp. 0705810.
45. Offertaler, L., Mo, F.M., Batkai, S., Liu, J., Begg, M., Razdan, R.K., et al. 2003. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol. Pharmacol. 63: 699-705. doi:10.1124/mol.63.3.699.
46. + channels by membrane lipids. Science (Washington, D.C), 304: 265-270. doi:10.1126/science.1094113.
47. Oz, M., Tchugunova, Y., and Dine, M. 2004. Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. Eur. J. Pharmacol. 502: 47-58. doi:10.1016/j.ejphar.2004.08.052.
48. 2+ fluxes in rabbit T-tubule membranes. Eur. J. Pharmacol. 404: 13-20. doi:10.1016/S0014- 2999(00)00396-4.
49. Pertwee, R.G. 2001. Cannabinoids and the gastrointestinal tract. Gut, 48: 859-867. doi:10.1136/gut.48.6.859.
50. + channels. Neuropharmacology, 35: 983-991. doi:10.1016/0028-3908(96)00130- X.
51. 1 cannabinoid receptor. Am. J. Physiol. 43: H375-H381.
52. + currents in rabbit arterial smooth muscle via protein kinase A. J. Physiol. 475: 9-13.
53. Ralevic, V. 2003. Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur. J. Pharmacol. 472: 1-21. doi:10.1016/S0014-2999(03)01813-2.
54. Randall, M.D., Alexander, S.P.H., Bennett, T., Boyd, E.A., Fry, J.R., Gardiner, S.M., et al. 1996. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun. 229: 114-120. doi:10.1006/bbrc.1996.1766.
55. Randall, M.D., and Kendall, D.A. 1997. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur. J. Pharmacol. 335: 205-209. doi:10.1016/S0014-2999(97)01237-5.
56. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284: 644-650.
57. 2+ channel. Eur. J. Pharmacol. 296: 347-350. doi:10.1016/0014-2999(95)00826-8.
58. 1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem. Biophys. Res. Commun. 243: 838-843. doi:10.1006/bbrc.1998.8187.
59. Twitchell, W., Brown, S., and Mackie, K. 1997. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78: 43-50.
60. Van den Bossche, I., and Vanheel, B. 2000. Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. Br. J. Pharmacol. 131: 85-93. doi:10. 1038/sj.bjp.0703521.
61. Vanheel, B., and Van de Voorde, J. 2001. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. J. Pharmacol. Exp. Ther. 296: 322-328.
62. Watanabe, H., Vriens, J., Prenen, J., Droogmans, G., Voets, T., and Nilius, B. 2003. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature (London), 424: 434-438. doi:10.1038/nature01807.
63. + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J. Physiol. 507: 117-129. doi:10.1111/j.1469-7793.1998.117bu.x.
64. White, R., Ho, W.S.V., Bottrill, F.E., Ford, W.R., and Hiley, C.R. 2001. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol. 134: 921-929. doi:10.1038/sj.bjp.0704333.
65. Yao, X., and Garland, C.J. 2005. Recent developments in vascular endothelial cell transient receptor potential channels. Circ. Res. 97: 853-863. doi:10.1161/01.RES.0000187473.85419.3e.
66. Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H.H., Sorgard, M., Di Marzo, V., Julius, D., and Hogestatt, E.D. 1999. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (London), 400: 452-457.